Lung-MAP: Master Protocol for Squamous Cell Lung Cancer
The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/789639.htm
- Syndication ID: 19695
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:14 PM
- Date Syndication Updated: Sunday, December 27, 2020 at 07:04 AM
Tags
General:
lung
protocol
nctn
lung-map
non-small cell
Embed Code Snippet
To get the embed code snippet please Login.
